Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset

被引:29
作者
Carayol, J [1 ]
Bonaïti-Pellié, C [1 ]
机构
[1] INSERM, U535, F-94817 Villejuif, France
关键词
ascertainment; retrospective likelihood; genotype restricted likelihood (GRL); penetrance; pedigree analysis;
D O I
10.1002/gepi.20007
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In diseases caused by deleterious gene mutations, knowledge of age-specific cumulative risks is necessary for medical management of mutation carriers. When pedigrees are ascertained through several affected persons, ascertainment bias can be corrected by using a retrospective likelihood. This likelihood is a function of the genotypes of pedigree members given their phenotypes and provides unbiased estimates of penetrance without modeling the selection process, provided that selection is independent of genotypes. However, since mutation testing is offered only to relatives of mutation carriers, the genotypes of family members are available only in mutated families and selection does depend on genotype. In the present study, we quantified the bias due to selection on genotype using simulations. We found that this bias depended on the true penetrance value: the lower the penetrance, the higher the bias (risk by age 80 estimated to be 46% for a true penetrance value of 20%). When age of onset is added to the selection criteria, as usually done, we showed that the bias was even higher. We modified the conditioning in the retrospective likelihood, what we call "genotype restricted likelihood" (GRL) Using simulations, we show that this method provided unbiased parameter estimates under all the selection designs considered. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 25 条
[1]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[2]  
2-C
[3]   Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [J].
Aarnio, M ;
Mecklin, JP ;
Aaltonen, LA ;
NystromLahti, M ;
Jarvinen, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) :430-433
[4]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[5]   A CONFIDENCE-INTERVAL FOR THE MEDIAN SURVIVAL-TIME [J].
BROOKMEYER, R ;
CROWLEY, J .
BIOMETRICS, 1982, 38 (01) :29-41
[6]   Hereditary non-polyposis colorectal cancer:: current risks of colorectal cancer largely overestimated [J].
Carayol, J ;
Khlat, M ;
Maccario, J ;
Bonaïti-Pellié, C .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) :335-339
[7]   EFFECTS OF MIS-SPECIFYING GENETIC-PARAMETERS IN LOD SCORE ANALYSIS [J].
CLERGETDARPOUX, F ;
BONAITIPELLIE, C ;
HOCHEZ, J .
BIOMETRICS, 1986, 42 (02) :393-399
[8]   Breast cancer genes - What are the real risks? [J].
Easton, D .
NATURE GENETICS, 1997, 16 (03) :210-211
[9]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[10]  
EASTON DF, 1993, AM J HUM GENET, V52, P678